These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26545710)

  • 1. Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt/β-catenin signaling.
    Martherus R; Jain R; Takagi K; Mendsaikhan U; Turdi S; Osinska H; James JF; Kramer K; Purevjav E; Towbin JA
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H174-87. PubMed ID: 26545710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Yang Z; Bowles NE; Scherer SE; Taylor MD; Kearney DL; Ge S; Nadvoretskiy VV; DeFreitas G; Carabello B; Brandon LI; Godsel LM; Green KJ; Saffitz JE; Li H; Danieli GA; Calkins H; Marcus F; Towbin JA
    Circ Res; 2006 Sep; 99(6):646-55. PubMed ID: 16917092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.
    Smith ED; Lakdawala NK; Papoutsidakis N; Aubert G; Mazzanti A; McCanta AC; Agarwal PP; Arscott P; Dellefave-Castillo LM; Vorovich EE; Nutakki K; Wilsbacher LD; Priori SG; Jacoby DL; McNally EM; Helms AS
    Circulation; 2020 Jun; 141(23):1872-1884. PubMed ID: 32372669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK3- and PRMT-1-dependent modifications of desmoplakin control desmoplakin-cytoskeleton dynamics.
    Albrecht LV; Zhang L; Shabanowitz J; Purevjav E; Towbin JA; Hunt DF; Green KJ
    J Cell Biol; 2015 Mar; 208(5):597-612. PubMed ID: 25733715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model.
    Lyon RC; Mezzano V; Wright AT; Pfeiffer E; Chuang J; Banares K; Castaneda A; Ouyang K; Cui L; Contu R; Gu Y; Evans SM; Omens JH; Peterson KL; McCulloch AD; Sheikh F
    Hum Mol Genet; 2014 Mar; 23(5):1134-50. PubMed ID: 24108106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study.
    Gomes J; Finlay M; Ahmed AK; Ciaccio EJ; Asimaki A; Saffitz JE; Quarta G; Nobles M; Syrris P; Chaubey S; McKenna WJ; Tinker A; Lambiase PD
    Eur Heart J; 2012 Aug; 33(15):1942-53. PubMed ID: 22240500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing identified novel Desmoplakin frame-shift variant in patients with Arrhythmogenic cardiomyopathy.
    Lin X; Ma Y; Cai Z; Wang Q; Wang L; Huo Z; Hu D; Wang J; Xiang M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):74. PubMed ID: 32046637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic inactivation of β-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy.
    Olcum M; Fan S; Rouhi L; Cheedipudi S; Cathcart B; Jeong HH; Zhao Z; Gurha P; Marian AJ
    Cardiovasc Res; 2023 Dec; 119(17):2712-2728. PubMed ID: 37625794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.
    Cheedipudi SM; Hu J; Fan S; Yuan P; Karmouch J; Czernuszewicz G; Robertson MJ; Coarfa C; Hong K; Yao Y; Campbell H; Wehrens X; Gurha P; Marian AJ
    Cardiovasc Res; 2020 May; 116(6):1199-1213. PubMed ID: 31350552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of cardiac Wnt/β-catenin signalling in desmoplakin-deficient AC8 zebrafish models is rescuable by genetic and pharmacological intervention.
    Giuliodori A; Beffagna G; Marchetto G; Fornetto C; Vanzi F; Toppo S; Facchinello N; Santimaria M; Vettori A; Rizzo S; Della Barbera M; Pilichou K; Argenton F; Thiene G; Tiso N; Basso C
    Cardiovasc Res; 2018 Jul; 114(8):1082-1097. PubMed ID: 29522173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right ventricular remodeling induced by prolonged excessive endurance exercise is mediated by upregulating Wnt/β-catenin signaling in rats.
    Maleki F; Mehrabani J
    Int J Cardiol; 2024 Oct; 413():132316. PubMed ID: 38977222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.
    Garcia-Gras E; Lombardi R; Giocondo MJ; Willerson JT; Schneider MD; Khoury DS; Marian AJ
    J Clin Invest; 2006 Jul; 116(7):2012-21. PubMed ID: 16823493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of protein phosphatase 2A in a murine model of chronic myocardial infarction leads to increased adverse remodeling but restores the regulation of β-catenin by glycogen synthase kinase 3β.
    Hoehn M; Zhang Y; Xu J; Gergs U; Boknik P; Werdan K; Neumann J; Ebelt H
    Int J Cardiol; 2015 Mar; 183():39-46. PubMed ID: 25662052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The
    Orgil BO; Munkhsaikhan U; Pierre JF; Li N; Xu F; Alberson NR; Johnson JN; Wetzel GT; Boukens BJD; Lu L; Towbin JA; Purevjav E
    Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H866-H880. PubMed ID: 37083466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy.
    Heliö K; Kangas-Kontio T; Weckström S; Vanninen SUM; Aalto-Setälä K; Alastalo TP; Myllykangas S; Heliö TM; Koskenvuo JW
    BMC Med Genet; 2020 Jan; 21(1):19. PubMed ID: 32005173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation.
    Castelletti S; Vischer AS; Syrris P; Crotti L; Spazzolini C; Ghidoni A; Parati G; Jenkins S; Kotta MC; McKenna WJ; Schwartz PJ; Pantazis A
    Int J Cardiol; 2017 Dec; 249():268-273. PubMed ID: 28527814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes.
    Karmouch J; Zhou QQ; Miyake CY; Lombardi R; Kretzschmar K; Bannier-Hélaouët M; Clevers H; Wehrens XHT; Willerson JT; Marian AJ
    Circ Res; 2017 Dec; 121(12):1346-1359. PubMed ID: 29018034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2.
    Cruz FM; Sanz-Rosa D; Roche-Molina M; García-Prieto J; García-Ruiz JM; Pizarro G; Jiménez-Borreguero LJ; Torres M; Bernad A; Ruíz-Cabello J; Fuster V; Ibáñez B; Bernal JA
    J Am Coll Cardiol; 2015 Apr; 65(14):1438-50. PubMed ID: 25857910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice.
    Kirchhof P; Fabritz L; Zwiener M; Witt H; Schäfers M; Zellerhoff S; Paul M; Athai T; Hiller KH; Baba HA; Breithardt G; Ruiz P; Wichter T; Levkau B
    Circulation; 2006 Oct; 114(17):1799-806. PubMed ID: 17030684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signalling and miRNA dysregulation.
    Calore M; Lorenzon A; Vitiello L; Poloni G; Khan MAF; Beffagna G; Dazzo E; Sacchetto C; Polishchuk R; Sabatelli P; Doliana R; Carnevale D; Lembo G; Bonaldo P; De Windt L; Braghetta P; Rampazzo A
    Cardiovasc Res; 2019 Mar; 115(4):739-751. PubMed ID: 30304392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.